Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Schrodinger is lead sponsor; 0 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- S-82026-08-05Employee stock plan
- 10-Q2026-08-05Quarterly report
- 8-K2026-08-05Current report (material event)
- 8-K2026-06-29Current report (material event)
- 8-K2026-06-23Current report (material event)
- 8-K2026-06-08Current report (material event)
- 8-K2026-05-20Current report (material event)
- SCHEDULE 13G/A2026-05-15SCHEDULE 13G/A
- 10-Q2026-05-05Quarterly report
- 8-K2026-05-05Current report (material event)
- SCHEDULE 13G/A2026-04-30SCHEDULE 13G/A
- SCHEDULE 13G2026-04-29SCHEDULE 13G
- ARS2026-04-28Annual report to holders
- DEFA14A2026-04-28DEFA14A
- DEF 14A2026-04-28Proxy statement
- SCHEDULE 13G/A2026-03-27SCHEDULE 13G/A
- 8-K2026-03-12Current report (material event)
- 10-K2026-02-25Annual report
- 8-K2026-02-25Current report (material event)
- SCHEDULE 13G/A2026-02-13SCHEDULE 13G/A
- 10-Q2025-11-05Quarterly report
- 8-K2025-11-05Current report (material event)
- SCHEDULE 13G/A2025-10-27SCHEDULE 13G/A
- 8-K2025-09-08Current report (material event)
- 10-Q2025-08-06Quarterly report
- 8-K2025-08-06Current report (material event)
- SCHEDULE 13G/A2025-07-18SCHEDULE 13G/A
- 8-K2025-06-18Current report (material event)
- 8-K2025-05-20Current report (material event)
- 8-K2025-05-19Current report (material event)
- S-82025-05-07Employee stock plan
- 10-Q2025-05-07Quarterly report
- 8-K2025-05-07Current report (material event)
- ARS2025-04-24Annual report to holders
- DEFA14A2025-04-24DEFA14A
- DEF 14A2025-04-24Proxy statement
- 8-K2025-04-11Current report (material event)
- 8-K2025-03-10Current report (material event)
- 10-K2025-02-26Annual report
- 8-K2025-02-26Current report (material event)
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.